Author

Now showing items 1-1 of 1

Should baseline PSA testing be performed in men aged 40 to detect those aged 50 or less who are at risk of aggressive prostate cancer?

Heyns, C. F. Fisher, M. Lecuona, A. Van Der Merwe, A. (Health and Medical Publishing Group (HMPG), 2011-09)

We aimed to evaluate the presenting features and treatment outcome of prostate cancer in men aged <50 years, in a region where prostate specific antigen (PSA) screening is not readily available and most men present with ...